Sanofi’s Amlitelimab Hits Key Endpoints in Phase 3...
Category : Clinical Trial Update 5 September 2025Sanofi announced positive results from COAST 1, a global phase 3 trial (NCT06130566) evaluating amli...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
CAGE Bio’s CGB-500 Shows Best-in-Class Results in...
Category : Clinical Trial Update 5 September 2025CAGE Bio has announced positive topline results from its Phase 2b, double-blinded, dose-ranging tria...
Accro Bioscience to Present Phase II Results of Or...
Category : Clinical Trial Update 5 September 2025Accro Bioscience (Accropeutics), a clinical-stage biotech focused on regulated cell death and relate...
AL-S Pharma Reports Positive Phase 2 Results of AP...
Category : Clinical Trial Update 5 September 2025AL-S Pharma AG today announced positive topline Phase 2 results for AP-101, a first-in-class investi...
Citryll Doses First Patient in Phase IIa “Citydrea...
Category : Clinical Trial Update 4 September 2025Citryll, a biotech company focused on immune-mediated inflammatory diseases, has dosed the first pat...
Latest Newsletter Post
-
AL-S Pharma Reports Positive Phase..
5 September 2025
-
Accro Bioscience to Present Phase I..
5 September 2025
-
CAGE Bio’s CGB-500 Shows Best-in-Cl..
5 September 2025
-
Sanofi’s Amlitelimab Hits Key Endpo..
5 September 2025
-
Sanofi to Showcase Broad Dermatolog..
4 September 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com